Efficacy and safety of the novel glycine transporter inhibitor BI 425809 once daily in patients with schizophrenia: a double-blind, randomised, placebo-controlled phase 2 study

Publication date: March 2021Source: The Lancet Psychiatry, Volume 8, Issue 3Author(s): W Wolfgang Fleischhacker, Jana Podhorna, Martina Gröschl, Sanjay Hake, Yihua Zhao, Songqiao Huang, Richard S E Keefe, Michael Desch, Ronald Brenner, David P Walling, Emilio Mantero-Atienza, Kazuyuki Nakagome, Stephane Pollentier
Source: The Lancet Psychiatry - Category: Psychiatry Source Type: research